Covance Becomes SCRS Global Impact Partner
The Society for Clinical Research Sites (SCRS) announced a two-year partnership with LabCorp.
The Society for Clinical Research Sites (SCRS) announced a two-year partnership with LabCorp. Under the agreement, Covance will participate as a Global Impact Partner (GIP), a relationship designed to facilitate dialogue between industry stakeholders and clinical research sites. As a GIP, Covance will participate on the SCRS Global Impact Board at an executive level, and work in tandem with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
